BioMarin Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
14.07.25
/
50%
€50.32
Target price
14.07.26
€96.68
Performance (%)
-6.40%
Price
20:29
€47.10
Summary
This prediction is currently active. With a performance of -6.40%, the BUY prediction for BioMarin Pharmaceutical Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 14.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.228% | -1.228% |
| iShares Core DAX® | 0.170% | 2.184% |
| iShares Nasdaq 100 | 0.515% | 0.370% |
| iShares Nikkei 225® | 1.614% | 6.357% |
| iShares S&P 500 | -0.719% | -0.275% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at JPMorgan Chase & Co. from $108.00 to $113.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.83
09.10.25
09.10.25
€102.23
09.10.26
09.10.26
0.58%
20:29
20:29
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€61.40
30.10.24
30.10.24
€100.36
30.10.25
30.10.25
-26.91%
31.10.25
31.10.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€108.11
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25